Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹3.59 Cr₹-3.33 Cr₹1.32 Cr₹8.21 Cr₹3.56 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BLISS GVS PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of BLISS GVS PHARMA is ₹3.59 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹3.59 Cr
Mar2023₹-3.33 Cr
Mar2022₹1.32 Cr
Mar2021₹8.21 Cr
Mar2020₹3.56 Cr

How is Deferred Tax Assets / Liabilities of BLISS GVS PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹3.59 Cr
Positive
Mar2023 ₹-3.33 Cr
Negative
Mar2022 ₹1.32 Cr
-83.88
Mar2021 ₹8.21 Cr
130.91
Mar2020 ₹3.56 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,241.6 Cr -3.5% -1.3% -2.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 2.3% 5.6% 21.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr 1.5% 4.2% 51.2% Stock Analytics
CIPLA ₹123,222.0 Cr 0% 2.9% 10% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr 0.6% 0.9% 23.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr 0.8% 1.8% -5.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-3.5%

-1.3%

-2.9%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses